KLHDC5, or Kelch Domain Containing Protein 5, is part of the broader kelch-like protein family, which is known for a characteristic kelch motif that forms a beta-propeller structure involved in protein-protein interactions. These proteins typically play roles in various cellular processes, including cytoskeleton organization, cellular morphology maintenance, and intracellular signaling pathways. KLHDC5 specifically has been implicated in the ubiquitination and subsequent proteasomal degradation of certain cellular proteins. By functioning as a substrate adapter in a CUL3 E3 ubiquitin ligase complex, KLHDC5 facilitates the transfer of ubiquitin from an E2 conjugating enzyme to specific substrates, marking them for degradation. This activity is crucial for maintaining protein homeostasis within the cell and for regulating the levels of proteins that are involved in cell cycle progression, apoptosis, and other critical cellular functions.
The inhibition of KLHDC5 can disrupt normal protein turnover processes, potentially leading to the accumulation of misfolded or damaged proteins, which can have deleterious effects on cellular health and function. One mechanism through which KLHDC5 may be inhibited involves the interference with its ability to bind to the CUL3 component of the E3 ubiquitin ligase complex. This could be achieved through mutations in KLHDC5 that alter its three-dimensional structure, thereby preventing it from effectively interacting with CUL3 or its substrates. Another potential mechanism of inhibition could be the post-translational modification of KLHDC5, such as phosphorylation or acetylation, which might alter its conformation or its interaction dynamics with other proteins in the ubiquitination pathway. Additionally, the expression of KLHDC5 itself could be downregulated at the transcriptional level through gene silencing mechanisms such as promoter methylation or histone modification, leading to decreased protein synthesis. These various forms of inhibition can significantly affect cellular processes by impairing the regulated degradation of key proteins, thus impacting cellular homeostasis and potentially contributing to the development of various diseases, including cancer and neurodegenerative disorders.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor that may impact proteins associated with ubiquitination processes. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $280.00 | 1 | |
Inhibits neddylation, a post-translational modification process. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Ubiquitin activation inhibitor, potentially affecting pathways associated with ubiquitination. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
An MDM2 antagonist that might indirectly influence ubiquitination processes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Influences protein degradation pathways, potentially impacting KLHDC5 indirectly. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
Autophagy inhibitor that can modulate protein turnover. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor potentially affecting protein degradation processes. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $60.00 $108.00 | 21 | |
Influences endocytosis, potentially impacting cellular processes associated with KLHDC5. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor with the potential to affect protein degradation indirectly. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Known to inhibit vacuolar H+-ATPase, impacting autophagy and lysosomal acidification. Potentially affects degradation. | ||||||